Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.


Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
02 2020
Historique:
received: 22 08 2019
revised: 26 09 2019
accepted: 01 10 2019
pubmed: 5 12 2019
medline: 1 5 2020
entrez: 5 12 2019
Statut: ppublish

Résumé

Pelvic exenteration and its reconstructive techniques have been associated with high postoperative morbidity and a negative impact on patient quality of life. The aim of our study was to compare postoperative complications and quality of life in patients undergoing continent compared with non-continent urinary diversion after pelvic exenteration for gynecologic malignancies. We designed a multicenter study of patients from 10 centers who underwent an anterior or total pelvic exenteration with urinary reconstruction for histologically confirmed persistent or recurrent gynecologic malignancy after previous treatment with radiotherapy. From January 2005 to September 2008, we included patients retrospectively, and from September 2008 to May 2009, patients were included prospectively which allowed collection of quality of life data. Demographic, surgical, and follow-up data were analyzed. Postoperative complications were classified according to the Clavien-Dindo classification. Quality of life was assessed using the European Organization for Research and Treatment of Cancer (EORTC)-QLQ-C30 (V.3.0) and EORTC-QLQ-OV28 quality of life questionnaires. We compared patients who underwent a continent urinary diversion with those who underwent a non-continent reconstruction. We included 148 patients, 92 retrospectively and 56 prospectively. Among them, 77.4% had recurrent disease and 22.6% persistent disease after the primary treatment. In 70 patients, a urinary continent diversion was performed, and 78 patients underwent a non-continent diversion. Median age of the continent and incontinent groups was 53.5 (range 33-78) years and 57 (26-79) years, respectively. There were no significant differences between the continent and non-continent groups in median length of hospitalization (28.5 vs 26 days, P=0.19), postoperative grade III-IV complications (42.9% vs 42.3%, P=0.95), complications needing surgical (27.9% vs 34.6%, P=0.39) or radiological (14.7% vs 12.8%, P=0.74) intervention, and complication type (digestive (23.2% vs 16.7%, P=0.32) and urinary (15.9% vs 16.7%, P=0.91)). There were no significant differences between the groups in global health, global quality of life, and body image perception scores 1 year after surgery. Continent and incontinent urinary reconstructions are equivalent in terms of postoperative complications and quality of life scores.

Sections du résumé

BACKGROUND
Pelvic exenteration and its reconstructive techniques have been associated with high postoperative morbidity and a negative impact on patient quality of life. The aim of our study was to compare postoperative complications and quality of life in patients undergoing continent compared with non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
METHODS
We designed a multicenter study of patients from 10 centers who underwent an anterior or total pelvic exenteration with urinary reconstruction for histologically confirmed persistent or recurrent gynecologic malignancy after previous treatment with radiotherapy. From January 2005 to September 2008, we included patients retrospectively, and from September 2008 to May 2009, patients were included prospectively which allowed collection of quality of life data. Demographic, surgical, and follow-up data were analyzed. Postoperative complications were classified according to the Clavien-Dindo classification. Quality of life was assessed using the European Organization for Research and Treatment of Cancer (EORTC)-QLQ-C30 (V.3.0) and EORTC-QLQ-OV28 quality of life questionnaires. We compared patients who underwent a continent urinary diversion with those who underwent a non-continent reconstruction.
RESULTS
We included 148 patients, 92 retrospectively and 56 prospectively. Among them, 77.4% had recurrent disease and 22.6% persistent disease after the primary treatment. In 70 patients, a urinary continent diversion was performed, and 78 patients underwent a non-continent diversion. Median age of the continent and incontinent groups was 53.5 (range 33-78) years and 57 (26-79) years, respectively. There were no significant differences between the continent and non-continent groups in median length of hospitalization (28.5 vs 26 days, P=0.19), postoperative grade III-IV complications (42.9% vs 42.3%, P=0.95), complications needing surgical (27.9% vs 34.6%, P=0.39) or radiological (14.7% vs 12.8%, P=0.74) intervention, and complication type (digestive (23.2% vs 16.7%, P=0.32) and urinary (15.9% vs 16.7%, P=0.91)). There were no significant differences between the groups in global health, global quality of life, and body image perception scores 1 year after surgery.
CONCLUSION
Continent and incontinent urinary reconstructions are equivalent in terms of postoperative complications and quality of life scores.

Identifiants

pubmed: 31796531
pii: ijgc-2019-000863
doi: 10.1136/ijgc-2019-000863
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-240

Informations de copyright

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Martina Aida Angeles (MA)

Surgical Oncology, Institut Claudius Regaud IUCT-oncopole, Toulouse, Occitanie, France.

Estelle Mallet (E)

Surgical Oncology, Centre Antoine-Lacassagne, Nice, Provence-Alpes-Côte d'Azu, France.

Philippe Rouanet (P)

Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France.

Bastien Cabarrou (B)

Biostatistics Unit, Institut Claudius Regaud, Toulouse, Occitanie, France.

Pierre Méeus (P)

Department of Surgical Oncology, Institut Léon Bérard, Lyon, France.

Eric Lambaudie (E)

Institut Paoli-Calmettes, Marseille, France.

Fabrice Foucher (F)

Department of Surgical Oncology, Centre Eugene Marquis, Rennes, Bretagne, France.

Fabrice Narducci (F)

Gynecology, Centre Oscar Lambret, lille, France.

Cécile Loaec (C)

Institut de Cancerologie de l'Ouest, Nantes, France.

Sebastien Gouy (S)

Institut Gustave-Roussy, Villejuif, Île-de-France, France.

Frederic Guyon (F)

Institut Bergonie, Bordeaux, France.

Frédéric Marchal (F)

Surgical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-les-Nancy, Lorraine, France.

Laurence Gladieff (L)

Medical Oncology, Institut Claudius Regaud, Toulouse, Occitanie, France.

Carlos Martínez-Gómez (C)

Surgical Oncology, Institut Claudius Regaud IUCT-oncopole, Toulouse, Occitanie, France.
INSERM CRCT 1, Toulouse, France.

Federico Migliorelli (F)

Department of Women, Children and Adolescents, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Alejandra Martinez (A)

INSERM CRCT 1, Toulouse, France.
Institut Claudius Regaud, Toulouse, Occitanie, France.

Gwenael Ferron (G)

Institut Claudius Regaud, Toulouse, Occitanie, France ferron.gwenael@iuct-oncopole.fr.
INSERM CRCT 19, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH